1,373
Views
99
CrossRef citations to date
0
Altmetric
Review

Direct and indirect cost of managing alzheimer’s disease and related dementias in the United States

, , &
Pages 189-202 | Received 16 Oct 2016, Accepted 27 Mar 2017, Published online: 12 Apr 2017

References

  • Tarawneh R, Holtzman DM. The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harb Perspect Med. 2012;2(5):a006148.
  • Alzheimer’s Association. 2016 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia. 2016;12(4):459–509.
  • Vann Jones SA, O’Brien JT. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med. 2014;44(4):673–683.
  • Hebert LE, Weuve J, Scherr PA, et al. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology. 2013;80(19):1778–1783.
  • Zhu CW, Scarmeas N, Torgan R, et al. Clinical characteristics and longitudinal changes of informal cost of Alzheimer’s disease in the community. J Am Geriatr Soc. 2006;54(10):1596–1602.
  • Joyce AT, Zhao Y, Bowman L, et al. Burden of illness among commercially insured patients with Alzheimer’s disease. Alzheimer’s Dement. 2007;3(3):204–210.
  • Kuo TC, Zhao Y, Weir S, et al. Implications of comorbidity on costs for patients with alzheimer disease. Med Care. 2008;46(8):839–846.
  • Zhu C, Torgan R, Scarmeas N, et al. Home health and informal care utilization and costs over time in Alzheimer’s disease. Home Health Care Serv Q. 2008;27(1):1–20.
  • Goldfeld KS, Stevenson DG, Hamel MB, et al. Medicare expenditures among nursing home residents with advanced dementia. Arch Intern Med. 2011;171(9):824–830.
  • Zhu CW, Scarmeas N, Ornstein K, et al. Health-care use and cost in dementia caregivers: longitudinal results from the Predictors Caregiver Study. Alzheimer’s Dement. 2015;11(4):444–454.
  • Suehs BT, Shah SN, Davis CD, et al. Household members of persons with Alzheimer’s disease: health conditions, healthcare resource use, and healthcare costs. J Am Geriatr Soc. 2014;62(3):435–441.
  • Suehs BT, Davis CD, Alvir J, et al. The clinical and economic burden of newly diagnosed alzheimer’s disease in a medicare advantage population. Am J Alzheimer’s Dis Other Demen. 2013;28(4):384–392.
  • Yang Z, Levey A. Gender differences: a lifetime analysis of the economic burden of alzheimer’s disease. Women’s Health Issues. 2015;25(5):436–440.
  • Hurd MD, Martorell P, Delavande A, et al. Monetary costs of dementia in the United States. New England J Med. 2013;368(14):1326–1334.
  • Kelley AS, McGarry K, Gorges R, et al. The burden of health care costs for patients with dementia in the last 5 years of life. Ann Intern Med. 2015;163(10):729–736.
  • Bharmal MF, Dedhiya S, Craig BA, et al. Incremental dementia-related expenditures in a medicaid population. Am J Geriatr Psychiatry. 2012;20(1):73–83.
  • Rattinger GB, Schwartz S, Mullins CD, et al. Dementia severity and the longitudinal costs of informal care in the Cache County population. Alzheimer’s and Dementia. 2015;11(8):946–954.
  • Zhu CW, Cosentino S, Ornstein K, et al. Medicare Utilization and expenditures around incident dementia in a multiethnic cohort. J Gerontol Ser Biol Sci Med Sci. 2015;70(11):1448–1453.
  • Deb A, Sambamoorthi U, Thornton JD, et al. Direct medical expenditures associated with Alzheimer’s and related dementias (ADRD) in a nationally representative sample of older adults – an excess cost approach. Aging Ment Health. 2017;1–6.
  • Lin PJ, Zhong Y, Fillit HM, et al. Medicare expenditures of individuals with alzheimer’s disease and related dementias or mild cognitive impairment before and after diagnosis. J Am Geriatr Soc. 2016;64(8):1549–1557.
  • Yang Z, Zhang K, Lin PJ, et al. A longitudinal analysis of the lifetime cost of dementia. Health Serv Res. 2012;47(4):1660–1678.
  • US Bureau of Labor Statistics. Consumer price index for all urban consumers: medical care services. (2017). Available at https://data.bls.gov/cgi-bin/surveymost?cu
  • Zhu CW, Scarmeas N, Torgan R, et al. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease. Neurology. 2006;67(6):998–1005.
  • Miller EA, Rosenheck RA, Schneider LS. Assessing the relationship between health utilities, quality of life, and health care costs in alzheimer’s disease: the catie-ad study. Curr Alzheimer Res. 2010;7(4):348–357.
  • Murman DL, Eye AV, Sherwood PR, et al. Evaluated need, costs of care, and payer perspective in degenerative dementia patients cared for in the United States. Alzheimer Dis Assoc Disord. 2007;21(1):39–48.
  • Gilligan AM, Malone DC, Warholak TL, et al. Health disparities in cost of care in patients with Alzheimer’s disease: an analysis across 4 state medicaid populations. Am J Alzheimer’s Dis Other Demen. 2013;28(1):84–92.
  • Gorina Y, Kramarow EA. Identifying chronic conditions in medicare claims data: evaluating the chronic condition data warehouse algorithm. Health Serv Res. 2011;46(5):1610–1627.
  • Taylor DH, Østbye T, Langa KM, et al. The accuracy of medicare claims as an epidemiological tool: the case of dementia revisited. J. Alzheimers Dis. 2009;17(4):807–815.
  • Hunter CA, Kirson NY, Desai U, et al. Medical costs of Alzheimer’s disease misdiagnosis among US Medicare beneficiaries. Alzheimer Dement. 2015;11(8):887–895.
  • Gilden DM, Kubisiak JM, Sarsour K, et al. Diagnostic pathways to Alzheimer disease costs incurred in a medicare population. Alzheimer Dis Assoc Disord. 2015;29(4):330–337.
  • Hurd MD, Martorell P, Langa K. Future Monetary Costs of Dementia in the United States under alternative dementia prevalence scenarios. J Popul Ageing. 2015;8(1–2):101–112.
  • Brookmeyer R, Corrada MM, Curriero FC, et al. Survival following a diagnosis of alzheimer disease. Arch Neurol. 2002;59(11):1764–1767.
  • Arrighi HM, Neumann PJ, Lieberburg IM, et al. Lethality of Alzheimer disease and its impact on nursing home placement. Alzheimer Dis Assoc Disord. 2010;24(1):90–95.
  • World Health Organization. Out-of-pocket expenditure on health as a percentage of private expenditure on health (US$). (2016). Available at http://www.who.int/gho/health_financing/out_pocket_expenditure/en/
  • Cubanski J, Swoope C, Damico A, et al. How much is enough? Out-of-pocket spending among medicare beneficiaries: a chartbook. (2014). Available at http://files.kff.org/attachment/how-much-is-enough-out-of-pocket-spending-among-medicare-beneficiaries-a-chartbook-report
  • Tamblyn R, Eguale T, Huang A, et al. The incidence and determinants of primary nonadherence with prescribed medication in primary carea cohort studyprimary nonadherence with prescribed medication in primary care. Ann Intern Med. 2014;160(7):441–450.
  • Hoffman C, Schwartz K. Eroding access among nonelderly U.S. adults with chronic conditions: ten years of change. Health Aff (Millwood). 2008;27(5):w340–348.
  • Thorpe KE, Ogden LL, Galactionova K. Chronic conditions account for rise in Medicare spending from 1987 to 2006. Health Aff (Millwood). 2010;29(4):718–724.
  • Delavande A, Hurd MD, Martorell P, et al. Dementia and out-of-pocket spending on health care services. Alzheimer Dement. 2013;9(1):19–29.
  • Gruber-Baldini AL, Stuart B, Zuckerman IH, et al. Treatment of dementia in community-dwelling and institutionalized medicare beneficiaries. J Am Geriatr Soc. 2007;55(10):1508–1516.
  • Walsh E, Freiman M, Haber S, et al. Cost drivers for dually eligible beneficiaries: potentially avoidable hospitalizations from nursing facility, skilled nursing facility, and home and community based services waiver programs. (2010). Available at https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and Reports/Reports/downloads/costdriverstask2.pdf
  • Caring.com. Nearly Half of Family Caregivers Spend Over $5,000 Per Year on Caregiving Costs. (2014). Available at https://www.caring.com/about/news-room/costs-of-caregiving-2014
  • Feinberg L, Reinhard SC, Houser A, et al. Valuing the invaluable: 2011 update, the growing contributions and costs of family caregiving. Washington, DC: AARP Public Policy Institute. 2011;51:1–28.
  • Garrison LP Jr., Mansley EC, Abbott TA 3rd, et al. Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR drug cost task force report–part II. Value Health. 2010;13(1):8–13.
  • Brodaty H, Donkin M. Family caregivers of people with dementia. Dialogues Clin Neurosci. 2009;11(2):217–228.
  • Friedman EM, Shih RA, Langa KM, et al. US prevalence and predictors of informal caregiving for dementia. Health Aff (Millwood). 2015;34(10):1637–1641.
  • Carretero S, Garces J, Rodenas F, et al. The informal caregiver’s burden of dependent people: theory and empirical review. Arch Gerontol Geriatr. 2009;49(1):74–79.
  • Levine C. Depression in Caregivers of Patients with Dementia: A Greater Role for Physicians. J Gen Intern Med. 2003;18(12):1058–1059.
  • Kolanowski AM, Fick D, Waller JL, et al. Spouses of persons with dementia: their healthcare problems, utilization, and costs. Res Nurs Health. 2004;27(5):296–306.
  • Schulz R, Beach SR. Caregiving as a risk factor for mortality: the caregiver health effects study. Jama. 1999;282(23):2215–2219.
  • Tremont G. Family caregiving in dementia. Med Health R I. 2011;94(2):36–38.
  • Chaudhry B, Wang J, Wu S, et al. Systematic review: impact of health information technology on quality, efficiency, and costs of medical care. Ann Intern Med. 2006;144(10):742–752.
  • National Conference of States Legislatures. (2016). “Collecting health data: all-payer claims databases.” Retrieved 10/12/2016, from http://www.ncsl.org/research/health/collecting-health-data-all-payer-claims-database.aspx
  • Gobeille V. Liberty Mut. Ins. Co., 577 U.S. 1 (2016). Available at https://www.supremecourt.gov/opinions/15pdf/14-181_5426.pdf
  • National Academy for State Health Policy. Overview of state programs that utilize an assessment of Self-Funded ERISA Plans and/or Third Party Administrators. (2016). Available at http://nashp.org/states-with-assessments-on-self-funded-plans-andor-third-party-administrators/
  • Dubois B, Hampel H, Feldman HH, et al. Preclinical Alzheimer’s disease: definition, natural history, and diagnostic criteria. Alzheimer’s & Dementia: the Journal of the Alzheimer’s Association. 2016;12(3):292–323.
  • Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the national institute on aging-alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia. 2011;7(3):280–292.
  • Bharucha AJ, Anand V, Forlizzi J, et al. Intelligent assistive technology applications to dementia care: current capabilities, limitations, and future challenges. Am J Geriatr Psychiatry. 2009;17(2):88–104.
  • Shih RA, Concannon TW, Liu JL, et al. Improving dementia long-term care: A policy blueprint. Rand Corporat. 2014.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.